Screener
Perspective Therapeutics CATX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Perspective Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:34 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342512
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $48,488 | $30,629 |
| Short-term investments | 188,388 | 114,108 |
| Accounts receivable, net of allowance for doubtful accounts: $375 for each period | 269 | 6 |
| Prepaid expenses and other current assets | 4,378 | 3,646 |
| Total current assets | 241,523 | 148,389 |
| Noncurrent assets: |
ITEM 1 - FINANCIAL STATEMENTS
FAQ
- What is Perspective Therapeutics's short-term investments?
- Perspective Therapeutics (CATX) reported short-term investments of $188.39M in Q2 2026.
- How has Perspective Therapeutics's short-term investments changed year-over-year?
- Perspective Therapeutics's short-term investments increased by 15.8% year-over-year, from $162.73M to $188.39M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Perspective Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude